Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

epiretinal membrane/edema

Nuoroda įrašoma į mainų sritį
Puslapis 1 nuo 25 rezultatus

A Comparison of Visual Functions and Side-effects After DSAEK or DMEK for Fuchs' Endothelial Dystrophy

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Purpose: To investigate 3 different side-effects after DSAEK, DMEK, and cataract extraction (CE) in a randomized controlled trial with 12 months follow-up with CE as an additional control group. 1. To investigate the extend of subclinical cystoid macular edema CME and epiretinal membrane (ERM) after

Evaluation of OCT and Visual Field Changes After Vitrectomy and ILM Peeling

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Macular epiretinal membrane (ERM) is a disorder of the vitreomacular interface characterized by fibrocellular proliferation on the anterior surface of the internal limiting membrane (ILM) of the macula. Pars plana vitrectomy with ERM removal and inner limiting membrane peeling is the standard

Evaluation of Multifocal ERG and Visual Field Changes After Vitrectomy and ILM Peeling

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Macular epiretinal membrane (ERM) is a disorder of the vitreomacular interface characterized by fibrocellular proliferation on the anterior surface of the internal limiting membrane (ILM) of the macula. Pars plana vitrectomy with ERM removal and inner limiting membrane peeling is the standard

Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Retinitis pigmentosa (RP) is a progressive external retinal degeneration resulting from mutation in any of the 260 genes found in the retinal pigment epithelium (RPE). The progression rate and findings of the disease are heterogeneous according to genetic mutation and heredity type. The initial

Evaluation of Visual Functions After Pars Plana Vitrectomy With and Without Internal Limiting Membrane Peeling in RRD

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
interventional observational study comparing vitrectomy with versus without internal limiting membrane peeling in cases of rhegmatogenous retinal detachment.

Vitreomacular Interface Abnormalities in Diabetic Retinopathy Using OCT

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Diabetic retinopathy (DR) is a leading health concern and a major cause of blindness .DR can be complicated by scar tissue formation, macular edema tractional retinal detachment. Optical coherence tomography has found patient with DR has diffuse retinal thickening , cystoid macular edema ,posterior
Diabetic retinopathy is the number one cause of vision loss in working-age adults, and macular edema is the most frequent cause of visual impairment in diabetic patients. Diabetic macular edema (DME) has been treated by a number of different modalities including focal and grid laser, intravitreal
PROBLEM STATEMENT: Background Currently the DME (diabetic macular edema) can be treated with 2 types of intravitreous treatment: corticosteroids (Ozurdex) or antiangiogenic (Eylea). Until a few years ago it was treated with photocoagulation. But the most rapid advances have been made at the level of

Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Title: Evaluation and Comparison of Macular and Choroidal Thickness after Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis Purpose: The objective of this study is to evaluate if the using of intracameral moxifloxacin cause changes in macular and choroidal

IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This is a phase 4 prospective, nonrandomized, open label, interventional clinical trial. Study eyes will receive 5 required initial monthly IAI doses of 2 mg followed by 2q8 IAI for a total of 52 weeks; only one study eye from each patient will be enrolled. Starting at week 24, patients may be

Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Macular edema is a relatively common occurrence after pars plana vitrectomy. Kim et al described that 47% of eyes undergoing vitrectomy for epiretinal membrane, macular hole, or vitreous hemorrhage had evidence of macular thickening on optical coherence tomography scan.1 Post-vitrectomy macular

Epiretinal Membrane and Pseudophakic Cystoid Macular Edema

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija

Applicability of the Acai Fruit (Euterpe Oleracea) Dye for Chromovitrectomy in Humans

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The purpose of the present clinical trial in humans will be to test the impregnation capacity of the acai dye (10 and 25% concentrations) in the identification of the posterior hyaloid and ILM during vitreoretinal surgery in humans. Twenty-four patients that seek treatment at the Ophthalmology

Cohort Study of the Clinical Course of Macular Diseases in Kagawa

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija

Intravitreal Gas for Vitreomacular Adhesion

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Symptomatic vitreomacular adhesion (sVMA), also known as Vitreomacular traction (VMT) is thought to occur due to an anomalous or incomplete posterior vitreous detachment (PVD).1 Typical symptoms of VMT include decreased reading vision and metamorphopsia. Ultra-high resolution spectral-domain optical
Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge